CN1168713C - 制备鼻病毒蛋白酶抑制剂的合成路线以及关键的中间体 - Google Patents

制备鼻病毒蛋白酶抑制剂的合成路线以及关键的中间体 Download PDF

Info

Publication number
CN1168713C
CN1168713C CNB008118779A CN00811877A CN1168713C CN 1168713 C CN1168713 C CN 1168713C CN B008118779 A CNB008118779 A CN B008118779A CN 00811877 A CN00811877 A CN 00811877A CN 1168713 C CN1168713 C CN 1168713C
Authority
CN
China
Prior art keywords
compound
formula
reaction
group
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB008118779A
Other languages
English (en)
Chinese (zh)
Other versions
CN1374947A (zh
Inventor
ƽ
田清平
N·K·奈亚
S·巴布
��Ī������
陶军华
��˹��ŵ��
T·J·莫兰
С��׳
R·小达尼诺
L·J·小米彻尔
÷
T·P·雷马楚克
M·J·梅尔尼克
S·L·本德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agouron Pharmaceuticals LLC
Original Assignee
Agouron Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharmaceuticals LLC filed Critical Agouron Pharmaceuticals LLC
Publication of CN1374947A publication Critical patent/CN1374947A/zh
Application granted granted Critical
Publication of CN1168713C publication Critical patent/CN1168713C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/24—Stationary reactors without moving elements inside
    • B01J19/2415—Tubular reactors
    • B01J19/2435—Loop-type reactors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/24—Stationary reactors without moving elements inside
    • B01J19/2475—Membrane reactors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00051—Controlling the temperature
    • B01J2219/00074—Controlling the temperature by indirect heating or cooling employing heat exchange fluids
    • B01J2219/00087—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor
    • B01J2219/00099—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor the reactor being immersed in the heat exchange medium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00051—Controlling the temperature
    • B01J2219/00159—Controlling the temperature controlling multiple zones along the direction of flow, e.g. pre-heating and after-cooling

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
CNB008118779A 1999-08-24 2000-08-23 制备鼻病毒蛋白酶抑制剂的合成路线以及关键的中间体 Expired - Fee Related CN1168713C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15035899P 1999-08-24 1999-08-24
US60/150,358 1999-08-24

Publications (2)

Publication Number Publication Date
CN1374947A CN1374947A (zh) 2002-10-16
CN1168713C true CN1168713C (zh) 2004-09-29

Family

ID=22534156

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB008118779A Expired - Fee Related CN1168713C (zh) 1999-08-24 2000-08-23 制备鼻病毒蛋白酶抑制剂的合成路线以及关键的中间体

Country Status (20)

Country Link
EP (1) EP1206450A1 (hu)
JP (1) JP2003507453A (hu)
KR (1) KR20020046283A (hu)
CN (1) CN1168713C (hu)
AR (1) AR025380A1 (hu)
AU (1) AU770221B2 (hu)
BR (1) BR0013306A (hu)
CA (1) CA2376452A1 (hu)
CO (1) CO5200782A1 (hu)
CZ (1) CZ2002632A3 (hu)
HK (1) HK1049336B (hu)
HU (1) HUP0203365A3 (hu)
IL (1) IL147674A0 (hu)
MX (1) MXPA02001944A (hu)
PE (1) PE20010517A1 (hu)
PL (1) PL353997A1 (hu)
TW (1) TWI245040B (hu)
UY (1) UY26307A1 (hu)
WO (1) WO2001014329A1 (hu)
ZA (1) ZA200200504B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE248186T1 (de) 1998-04-30 2003-09-15 Agouron Pharma Antipicornavirale verbindungen, deren herstellung und verwendung
WO2001010894A2 (en) 1999-08-04 2001-02-15 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
PA8507801A1 (es) 1999-12-03 2002-08-26 Agouron Pharma Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis
PE20011277A1 (es) 2000-04-14 2002-01-07 Agouron Pharma Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis
WO2001096297A2 (en) 2000-06-14 2001-12-20 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
CN1309712C (zh) * 2004-04-02 2007-04-11 中国科学院上海有机化学研究所 Ag7088类化合物的关键中间体的前体及其合成方法
EP4114384A1 (en) 2020-03-06 2023-01-11 Pfizer Inc. Methods of inhibiting sars-cov-2 replication and treating coronavirus disease 2019
CN115260074B (zh) * 2022-08-02 2024-06-21 爱斯特（成都）生物制药股份有限公司 一种口服抗病毒药物Paxlovid中间体的制备方法
CN115322130B (zh) * 2022-08-02 2024-05-14 南京正济医药研究有限公司 制备(s)-2-(boc-氨基)-3-[(s)-2-氧代-3-吡咯烷基]丙酸甲酯

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2254343A1 (en) * 1996-05-14 1997-11-20 Agouron Pharmaceuticals, Inc. Inhibitors of picornavirus 3c proteases and methods for their use and preparation
NZ501315A (en) * 1997-03-28 2001-08-31 Agouron Pharma Carbonyl-ethyl-carboxamidyl-alkane and carbonyl-ethyl-thiocarboxamidyl-alkane derivatives useful as antipicornaviral agents
US5962487A (en) * 1997-12-16 1999-10-05 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds and methods for their use and preparation
ATE248186T1 (de) * 1998-04-30 2003-09-15 Agouron Pharma Antipicornavirale verbindungen, deren herstellung und verwendung

Also Published As

Publication number Publication date
TWI245040B (en) 2005-12-11
HUP0203365A2 (hu) 2003-02-28
AU6797100A (en) 2001-03-19
WO2001014329A1 (en) 2001-03-01
EP1206450A1 (en) 2002-05-22
CN1374947A (zh) 2002-10-16
HK1049336A1 (en) 2003-05-09
IL147674A0 (en) 2002-08-14
CO5200782A1 (es) 2002-09-27
MXPA02001944A (es) 2002-10-31
ZA200200504B (en) 2003-03-26
KR20020046283A (ko) 2002-06-20
JP2003507453A (ja) 2003-02-25
AR025380A1 (es) 2002-11-20
CA2376452A1 (en) 2001-03-01
UY26307A1 (es) 2001-04-30
HK1049336B (zh) 2005-05-20
PL353997A1 (en) 2003-12-15
CZ2002632A3 (cs) 2003-04-16
BR0013306A (pt) 2002-05-28
PE20010517A1 (es) 2001-05-16
AU770221B2 (en) 2004-02-19
HUP0203365A3 (en) 2003-12-29

Similar Documents

Publication Publication Date Title
CN1231478C (zh) 光学活性的哌啶中间体的制备方法和该中间体
CN1844118A (zh) 可抑制细胞释放肿瘤坏死因子的哌啶－2，6－二酮衍生物
CN1805931A (zh) 制备(1r,2s,5s)－6,6－二甲基－3－氮杂双环[3,1,0]己烷－2－羧酸酯或其盐的方法和中间体
CN1639187A (zh) 有效抗c型肝炎病毒的大环肽
CN1845921A (zh) 金刚烷和氮杂双环－辛烷及壬烷衍生物、其制备方法及其作为dpp－iv抑制剂的用途
CN1168713C (zh) 制备鼻病毒蛋白酶抑制剂的合成路线以及关键的中间体
CN1062729A (zh) 可用作血管紧张肽转化酶抑制剂的含氨基和硝基的三环新化合物
CN1043042C (zh) 7－[2－(2－氨基噻唑－4－基)－2－(Z)－羟亚胺基－乙酰胺基]－3－(甲氧甲基)－3－头孢烯－4－羧酸－α－(2,2－二甲基丙酰氧)乙酯拆分的方法
CN101065361A (zh) 具有取代己内酰胺环的bengamides，其制备方法，含有它们的组合物与其用途
CN1255498A (zh) 生长激素促分泌剂的制备方法和中间体
CN1174553A (zh) 丙烯酰胺衍生物及其制造方法
CN1069491A (zh) 2-(哌啶-1-基)乙醇衍生物，其制法及其治疗应用
CN1066723C (zh) Hiv蛋白酶抑制剂的中间体及其制备方法
CN1046715C (zh) Ｈｉｖ蛋白酶抑制剂的制备方法
CN1026785C (zh) 黄皮酰胺，新黄皮酰胺及其衍生物的制备方法
CN1144804C (zh) 苯并[c]喹嗪衍生物及其作为5α-还原酶抑制剂的用途
CN1407969A (zh) 氧亚氨基链烷酸衍生物的制备方法
CN1784378A (zh) 4－羟基异亮氨酸及其衍生物的合成方法
US6774243B2 (en) Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
CN1241924C (zh) 制备脑啡肽酶与血管紧张素转化酶抑制剂中间体的新方法及其中间体
CN1162408C (zh) 从四氢呋喃化合物制备噁唑啉化合物的方法
CN1166668C (zh) 取代的[1,4]-二氮杂�并[6,7,1-hi]-吲哚-4-酮类的制备方法
CN1221505C (zh) 制备链烷二醇衍生物方法
CN1100033C (zh) 苯乙醇氨基－1,2,3,4－四氢化萘氧烃基酰胺衍生物
CN1426399A (zh) 喹诺酮甲酸及其中间体的制备方法

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee